A cohesive phylogenetic cluster that is limited to enteric bacteria and a few closely related genera possesses a bifunctional protein that is known as the T-protein and is encoded by tyrA. The T-protein carries catalytic domains for chorismate mutase and for cyclohexadienyl dehydrogenase. Cyclohexadienyl dehydrogenase can utilize prephenate or L-arogenate as alternative substrates. A portion of the tyrA gene cloned from Erwinia herbicola was deleted in vifru with exonuclease I11 and fused in-frame with a 5' portion of lac2 to yield a new gene, denoted tyrA *, in which 37 N-terminal amino acids of the T-protein are replaced by 18 amino acids encoded by the polycloning site/S portion of the lac2 a-peptide of pUC19. The TyrA* protein retained dehydrogenase activity but lacked mutase activity, thus demonstrating the separability of the two catalytic domains. While the K, of the TyrA* dehydrogenase for NAD+ remained unaltered, the K, for prephenate was fourfold greater and the Vmax was almost twofold greater than observed for the parental T-protein dehydrogenase. Activity with L-arogenate, normally a relatively poor substrate, was reduced to a negligible level. The prephenate dehydrogenase activity encoded by tyrA * was hypersensitive to feedback inhibition by L-tyrosine (a competitive inhibitor with respect to prephenate), partly because the affinity for prephenate was reduced and partly because the Ki value for L-tyrosine was decreased from 66 VM to 14 PM. Thus, excision of a portion of the chorismate mutase domain is shown to result in multiple extra-domain effects upon the cyclohexadienyl dehydrogenase domain of the bifunctional protein. These include alterations in apparent substrate specificity, isoelectric point, stability, catalytic properties and regulatory properties.
Introduction
The biochemical pathways which specify the biosynthesis of L-tyrosine and L-phenylalanine in enteric bacteria utilize two bifunctional proteins which are in competition for chorismate at a metabolic branchpoint. The P-protein encoded by pheA possesses catalytic domains for chorismate mutase (CM-P) and for prephenate dehydratase (converts prephenate to phenylpyruvate). The T-protein encoded by tyrA possesses catalytic domains for chorismate mutase (CM-T) and for prephenate dehydrogenase (converts prephenate to 4-hydroxy- Abbreviations : CM-F, a monofunctional chorismate mutase protein ; CM-P, the chorismate mutase domain of the bifunctional P-protein; CM-T, the chorismate mutase domain of the bifunctional T-protein.
The nucleotide sequence data reported in this paper have been submitted to EMBL and have been assigned the accession number X60420. phenylpyruvate). This was originally shown in the landmark paper by Cotton & Gibson (1965) who studied Escherichia coli and Klebsiella pneumoniae (originally named Aerobacter aerogenes). The limited distribution of the T-protein in enteric bacteria -Alteromonas and Aeromonas -compared to the widespread presence of the P-protein throughout two of the three main subdivisions of Gram-negative bacteria, has been established more recently (Ahmad & Jensen, 1986) . The T-protein dehydrogenase has proven to be a cyclohexadienyl dehydrogenase (able to use prephenate and L-arogenate as alternative substrates), in contrast to the highly specific P-protein dehydratase which cannot function as a cyclohexadienyl dehydratase (Ahmad & Jensen, 1987) . Many enteric bacteria, but not E. coli, possess a third isoenzyme of chorismate mutase which is monofunctional (i.e. has one catalytic domain) and has been denoted CM-F (Ahmad et al., 1990) .
The tyrA andpheA genes are contiguous (tail-to-tail) in E. coli, and homologous chorismate mutase domains are indicated by the similarity of the N-terminal sequences O 1992 SGM of the T-protein and the P-protein (Hudson & Davidson, 1984) . It has been clear for some time that the two catalytic functions of the P-protein are largely independent, on the criterion that mutants lacking only CM-P activity or only prephenate dehydratase activity could be isolated (Baldwin & Davidson, 1981) . A genetic construct derived from pheA has also been described (Stewart et al., 1990) which encodes a monofunctional CM-P that lacks the prephenate dehydratase domain. The separability of the two T-protein functions had remained in doubt (Rood et al., 1982) until recently, when molecular-genetic approaches established the genetic separability of functional CM-T and dehydrogenase components in E. coli (Maruya et al., 1987) . In the latter study, no enzymological characterizations of the new monofunctional enzymes were given.
Erwinia herbicola is an organism whose pathway of aromatic amino acid biosynthesis is more typical of enteric bacteria than is that of E. coli (Ahmad et al., 1990) . A DNA fragment carryingpheA and tyrA genes from E. herbicola has been cloned by functional complementation of E. coli (T. Xia and others, unpublished) as part of a project to compare gene organization in enteric bacteria. Subcloning procedures led fortuitously to the isolation of plasmids lacking a portion of the CM-T domain encoded by tyrA. The resulting monofunctional protein possessed multiple alterations of biocatalysis within the surviving dehydrogenase domain that are described here.
Methods
Media, strains and plasmids. Enriched growth medium (LB medium) and minimal medium (M9 salts) were prepared as described by Sambrook et al. (1989) . Ampicillin (50 pg m1-I) and vitamin B, (17 pg ml-I) were added when required. Supplementation with L-phenylalanine or L-tyrosine, when appropriate, was at 50 pg ml-l . Agar (2%, w/v) was added for solid media. The description and origin of strains and plasmids are given in Table 1. DNA manipulations. Plasmids pJX2, pJX3 and pJX4 were constructed from pJXl ( Fig. 1) . Plasmid pJXl carries the E. herbicola tyrA and pheA genes isolated from a Suu3A genomic library generated in pUC 18 (Xia et al., 1992) . For deletion of nucleotides from the 5' portion of the tyrA gene, pJXl DNA was linearized by digestion with NcoI, treated with exonuclease I11 as described by Henikoff (1984) , and then mung bean nuclease was used to create blunt ends. After treatment with EcoRI, this DNA preparation was ligated to pUC19 which had been digested with EcoRI and SmaI. The ligation mixture was used to transform E. coli JP2255. Eleven transformants, able to grow on M9 medium lacking L-tyrosine and L-phenylalanine, were found to contain the truncated tyrA gene, and one of them (designated pJX2) was used for further study.
For construction of pJX3, pJX2 DNA was linearized by digestion with SstII, treated with mung bean nuclease to make blunt ends, and then digested with HindIII. A fragment of about 1.6 kb was ligated to pUC19 DNA that had been digested with SmaI and HindIII, and then used to transform E. coli JP2255. For construction of pJX4, the 2.7 kb DNA sequencing. Caesium chloride/ethidium bromide buoyant density gradient centrifugation (Humphreys et al., 1975) was used for large-scale purification of the recombinant plasmid pJX2. The first 300 base pairs were sequenced from the T7/T3cr sequencing primer by a methodology using fluorescent chain-terminating dideoxy nucleotides (Prober et al., 1987) at thk DNA Core Facility of the University of Florida. The nucleotide and deduced peptide sequences were analysed by using the University of Wisconsin Genetics Computer Group (GCG) package (Devereux et al., 1984) .
Amino acid sequencing. The sequencing of N-terminal amino acids was carried out at the Protein Chemistry Core Facility at the University of Florida.
Preparation of crude extracts. E. coli cells were grown at 37 "C in LB medium and harvested by centrifugation during the exponential growth phase. Cell pellets were resuspended in Buffer A (20mM-potassium phosphate and 1 mM-DTT, pH 7-2), and disrupted by sonication. Cell debris was removed by ultracentrifugation at 150000 g at 4 "C for 60 min, and the clear supernatant was saved.
Enzyme assays. Prephenate dehydrogenase and arogenate dehydrogenase were assayed as described previously (Byng et al., 1980) . The continuous formation of NADH was determined spectrophotofluorometrically (excitation wavelength 340 nm and emission wavelength 460 nm): 1 nmol NADH produced corresponds to 20 fluorescence units. One unit (U) of dehydrogenase activity forms 1 nmol NADH min-' at 37 "C. Chorismate mutase and prephenate dehydratase were assayed as described previously (Ahmad & Jensen, 1988) .
Protein concentrations of extracts were quantified by the procedure Pur8cation of TyrA* from E. coli JP2255(pJX2) and TyrA from E. coli JP2255(pJXZ). Column chromatographic steps of DEAE-cellulose (DE52), hydroxylapatite and Sephadex G-200 were carried out for TyrA* purification, while DE52 and hydroxylapatite chromatography were used for purification of TyrA. Crude extract (250 mg protein) was applied to a DE52 column (2.5 x 25 cm) equilibrated with Buffer A, and then eluted with a 600 ml linear KCl gradient ( 0 . 4 M) in Buffer A. Fractions of 3-5 ml were collected, and those showing high prephenate dehydrogenase activity were pooled and concentrated by use of an Amicon PM-10 membrane. The concentrated preparation was washed twice with Buffer A and applied to a hydroxylapatite column (1 -5 x 20 cm). The column was eluted with 600 ml of a linear gradient (20-300 mM) of potassium phosphate buffer (pH 7.2) containing 1 mM-DTT. Fractions of 3.5 ml were collected, and those having high enzyme activity were saved (in the case of TyrA), or pooled for the next step (in the case of TyrA*). The pooled TyrA* eluate fractions were concentrated to 1.5 ml by use of a PM-10 membrane and applied to a Sephadex G-200 column (2.5 x 98 cm). Protein was eluted with Buffer A, and fractions of 3 ml were collected.
Molecular mass estimations by gel-3ltration. The molecular masses of both purified TyrA and TyrA* were estimated by gel-filtration on a Sephadex G-200 column (see above) in the presence or absence of the inhibitor L-tyrosine. The elution buffer was Buffer A plus 100pM-L-tyrosine when enzyme was run in the presence of the inhibitor. Carbonic anhydrase (30 kDa), bovine serum albumin (67 kDa), alcohol dehydrogenase (1 50 kDa) and B-amylase (200 kDa) were used as molecular mass standards.
SDS-PAGE.
This was done by the procedure of Laemmli (1970) , using a 10% (w/v) polyacrylamide gel with the following molecular mass standards : a-lactalbumin (14.4 kDa), soybean trypsin inhibitor (20.1 kDa), carbonic anhydrase (30 kDa), ovalbumin (43 kDa), bovine serum albumin (67 kDa) and phosphorylase (94 kDa).
Biochemicals and chemicals.
Restriction enzymes, exonuclease 111, mung bean nuclease and T4 DNA ligase were obtained from Promega, Gibco-BRL, or New England Biolabs. Protein standards for SDS-PAGE were from Pharmacia. L-Tyrosine, NAD+, DTT, Sephadex G-200 and protein standards for gel-filtration were from Sigma. DEAE-cellulose (DE52) was from Whatman and hydroxylapatite was from Bio-Rad. Prephenate was prepared from culture supernatants of a tyrosine auxotroph of Salmonella typhirnurium (Dayan & Sprinson, 1970) , L-arogenate was isolated from the accumulation medium of the triple auxotroph of Neurospora crassa (Zamir et al., 1980) , and chorismate was prepared from Klebsiella pneumoniae 62-1 (Gibson, 1964) .
of Bradford (1976) .
Isolation of tyrA*
As depicted in Fig. 1 , the tyrA* construct (pJX2) was obtained from pJXl by utilizing exonuclease I11 to delete a portion of the 5' end of the E . herbicola tyrA. Eleven colonies were obtained by selection on M9 medium containing vitamin B1, each growing slowly in comparison with E. coli JP2255(pJXl). Plasmids isolated from each of the eleven clones were 5.4 kb in size, and were capable of transforming JP2255 to slow-growing strains in the absence of L-tyrosine. Given the 2.7 kb size of pUC19, the size of each insert is about 2.7 kb. One of these plasmids, designated pJX2, was selected for further study.
Sequence comparison of tyrA and tyrA* When the nucleotide sequence of tyrA (T. Xia and others, unpublished) was compared with that of tyrA*, it was found that 109 bp had been deleted from the 5' portion of tyrA by the exonuclease III/mung bean nuclease treatment used to generate tyrA*. Fig. 2 shows a comparison of the 5' regions of tyrA and tyrA*.
The 5' portion of tyrA* was identified as the site of a gene fusion, whereby the residual tyrA sequence was joined to the lac a-peptide/polycloning region in pUC 19 by replacement of the SmaIIEcoRI fragment. Fig. 2 shows that the sequence of tyrA* downstream from bp 55 matches exactly with the sequence of tyrA beginning with bp 110. A total of 55 bp intervenes between the start codon of the lac a-peptide gene and the axis of dyad symmetry for the SmaI cleavage site (Yanisch-Perron et al., 1985). Thus, the first 37 codons of tyrA were replaced by the first 18 codons of the lac a-peptide/polycloning site, and a recombinant codon (CAG) was created. The calculated size of TyrA* is 1934 Da less than the size of TyrA.
Confirmation of the foregoing conclusions was obtained by sequencing the N-terminal 19 amino acid residues of TyrA*. The sequence obtained matched exactly the first 19 amino acid residues (underlined in Fig. 2 ) predicted on the basis of the sequence obtained for the 5' terminus of tyrA*.
Expression of tyrA*
In contrast to control extracts prepared from JP2255(pUC 19) or JP2255(pUC 18), crude extracts prepared from cultures of JP2255(pJXl) exhibited substantial activities for chorismate mutase, prephenate dehydrogenase and prephenate dehydratase ( Table 2 ). The low level of chorismate mutase present in JP2255(pJX2) in comparison to that of JP2255(pJXl) indicated the probable absence of one of the two chorismate mutase isoenzymes. Table 2 also shows the total lack of chorismate mutase activity together with the presence of high dehydrogenase activity in JP2255 carrying a plasmid construct (pJX3) where tyrA* is present on a 1.6 kb fragment lacking most of pheA.
When the pheA tyrA* insert carried by pJX2 was placed in the opposite orientation of pUC18, this strain [JP2255(pJX4)] expressed the CM-P and prephenate dehydratase activities encoded by pheA, but failed to express TyrA*. This shows that t y A * is expressed from the lac promoter of pUC19, whereas pheA can be expressed from its own promoter.
DEAE-cellulose chromatography of crude extract from JP2255(pJX2) revealed a normal peak of chorismate mutase (CM-P) eluting in exact coincidence with prephenate dehydratase, as expected for the bifunctional P-protein (data not shown). However, a second isoenzyme of chorismate mutase (CM-T), one catalytic component of the bifunctional T-protein, was totally absent in the expected elution position coincident with the cyclohexadienyl dehydrogenase profile (assayed as prephenate dehydrogenase). Fig. 3 shows a comparison of the dehydrogenase elution profiles following DEAEcellulose chromatography of crude extract from JP2255(pJX2) containing TyrA* and extract from JP2255(pJXl) containing TyrA. Fig. 3(6) shows the co-elution of the CM-T and cyclohexadienyl dehydrogenase activities of TyrA at about 0.21 M-KCl. In contrast, TyrA* exhibited no CM-T activity, but did express a dehydrogenase activity having an altered elution position at about 0.17 M-KCl. Thus, TyrA* is less
The overproduction of TyrA in E. coli JP2255(pJXl) and TyrA* in E. coli JP2255(pJX2) facilitated their purification. Two chromatographic steps and three chromatographic steps were sufficient for purification to homogeneity of TyrA and TyrA*, respectively, as judged from SDS-PAGE. Fig. 4 shows that the subunit molecular mass of TyrA is about 41 kDa, while that of TyrA* is about 39 kDa. The size is consistent with the difference expected on the basis of sequence comparison (1.9 kDa). Sephadex G-200 gel-filtration indicated that the native molecular mass of TyrA was -81 kDa, while that of TyrA* was -75 kDa. Thus, both TyrA and TyrA* are dimers. In the presence of L-tyrosine during gelfiltration, the same molecular mass values were obtained for TyrA and for TyrA*. TyrA* was found to be hypersensitive to feedback inhibition by L-tyrosine compared to the dehydrogenase component of the T-protein. The inhibition curves shown in Fig. 5 indicate that 50% inhibition of the TyrA prephenate dehydrogenase activity requires 700 PM-L-tyrosine, whereas 50% inhibition of the TyrA* prephenate dehydrogenase activity requires only 87 VM-L-tyrosine. At 0-5 mM-L-tyrosine, TyrA* was completely inhibited, in comparison to 40% inhibition of TyrA.
Kinetic evaluation of the TyrA* and TyrA dehydrogenases showed Michaelis-Menten kinetics of substrate Fig. 5 . Inhibition curves comparing the sensitivities of prephenate dehydrogenase activity from TyrA or from TyrA* to feedback inhibition by L-tyrosine. Activity determinations were carried out as described in Methods. A relative activity of 100% corresponds to 27 units of activity. saturation and competitive inhibition by L-tyrosine with respect to prephenate utilization (data not shown). Both TyrA and TyrA* exhibited identical K , values of 0.07 mM for NAD+. However, TyrA* had a K , value for prephenate of 0.25 mM, four times greater than that of TyrA (0.06m~). The affinity of TyrA* for L-tyrosine (Ki = 14 p~) was about fivefold greater than that of TyrA Multiple biocatalytic alterations via gene cleavage 1 3 15 (Ki = 66 p~) . The apparent V,,, of TyrA* for prephenate was about twofold greater than that of TyrA. The V,,, of TyrA was 1.3 x lo5 U min-l mg-l, and the V,,, of TyrA* was 2.4 x lo5 U min-l mg-l.
TyrA carries a cyclohexadienyl dehydrogenase domain that is able to utilize L-arogenate about 8% as well as prephenate at substrate saturation. Since the two cyclohexadienyl substrates bind at a common site, the decreased affinity for prephenate is accompanied by a reduction of the affinity for L-arogenate to a level near the limits of detection. In effect, the modification of the T-protein to produce TyrA* has resulted in the conversion of the CDH domain to a prephenate dehydrogenase.
TyrA* was also compared to TyrA with respect to thermal stability, protection conferred by DTT and pH optimum. The pH optimum for both dehydrogenase proteins was 8.0 when assayed in 50mM-potassium phosphate buffer containing 1.0 mM-DTT. TyrA* exhibited an increased sensitivity to thermal inactivation. At 45 "C in the presence of DTT the half-life of TyrA was 8 min, compared to 4.5 min for TyrA*. Under the same conditions, but in the absence of DTT the halflife of TyrA was 4 min, compared to 3 min for TyrA*. Thus, the protection conferred by DTT upon TyrA was retained in TyrA*.
Discussion
It appears that a very limited number of cleavage sites exist in tyrA that will yield an operational monofunctional dehydrogenase. Although the exonuclease I11 digestion procedure carried out should have produced a size distribution of fragments, the inserts in all 11 independent recombinants cloned in pUC19 were of similar size. The point of cleavage was well within the CM-T portion of tyrA since only about 12 % of the amino terminus of the T-protein was excised, whereas the region of homology with CM-P is at least 25% of the T-protein.
Objectives of biotechnology often include the systematic alteration of biocatalytic properties. In this context, some biocatalytic properties of the newly created monofunctional dehydrogenase were dramatically and pleiotropically altered by replacement of the aminoterminal fragment of the T-protein. The affinity for prephenate decreased fourfold, the affinity for NAD+ remained unchanged, and the affinity for L-tyrosine (feedback inhibitor) increased almost fivefold. The V,,, for prephenate increased almost twofold. The decreased affinity for both cyclohexadienyl substrates effectively narrowed the substrate specificity, transforming the original cyclohexadienyl dehydrogenase to a prephenate deh ydrogenase.
These multiple effects upon the dehydrogenase domain caused by a partial deletion of the mutase domain indicate intimate protein-protein relationships between the mutase and dehydrogenase components of the T-protein molecule. This is consistent with results of enzymological studies (Heyde, 1979 ; Heyde & Morrison, 1978 ; Koch et al., 1972) , which led to earlier speculations that tyrA might possess only a single, complex catalytic domain. The T-protein probably originated by fusion of genes encoding a monofunctional species of chorismate mutase and cyclohexadienyl dehydrogenase. If so, the catalytic domains must have co-evolved to develop domain-domain interactions.
The tyrA pheA auxotroph o f E. coli possessing the pheA and tyrA* genes from Erwinia demonstrates the physiological potential for CM-P to provide prephenate for tyrosine biosynthesis when CM-T is absent. The amplification ofpheA on the high-copy-number plasmid pUC 19 probably results in high intracellular levels of prephenate since prephenate dehydratase is vastly more sensitive to feedback inhibition by L-phenylalanine than is CM-P. Under these conditions prephenate availability to TyrA* would presumably be greatly increased. In this context, it is of interest that one small phylogenetic cluster of pseudomonads in nature has been reported to utilize the CM-P component of the P-protein for both phenylalanine and tyrosine biosynthesis in a 'channel-shuttle' mechanism (Ahmad & Jensen, 1988) .
